Samlyn Capital’s Aclaris Therapeutics ACRS Stock Holding History

Samlyn Capital’s Portfolio ACRS Stock Details ACRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$10M	Buy
2023 Q2	$13.9M	Buy
2023 Q1	$8.51M	Buy
2017 Q1	–	Sell
2016 Q4	$3.69M	Buy